International Clinical Trial: Single-center, randomized, open-label, single-dose, two-formulation, two-period, two-sequence, crossover bioequivalence study of fluconazole tablets in healthy Chinese subjects under fasting conditions

Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115461) titled 'Single-center, randomized, open-label, single-dose, two-formulation, two-period, two-sequence, crossover bioequivalence study of fluconazole tablets in healthy Chinese subjects under fasting conditions' on Dec. 26, 2025.

Study Type: Interventional study

Study Design: Cross-over

Primary Sponsor: The Affiliated Panyu Central Hospital, Guangzhou Medical University

Condition: Invasive fungal infection

Intervention: T-R group:Take the test formulation (T) 200mg (1 tablet) orally on an empty stomach. After 7 days, take the reference formulation (R) 200mg (1 tablet) orally on an empty stomach.

Recruitment Status...